The National Institute on Drug Abuse (NIDA) awarded Booz Allen Hamilton Inc. a $47,000,000 single-award Indefinite Delivery Contract to establish and maintain the NIDA Developmental Studies Biorepository and Analysis Center. This center will support the Adolescent Brain Cognitive Development (ABCD) Study and HEALthy Brain and Child Development (HBCD) Study by receiving, processing, storing, and distributing biospecimen samples in a CLIA-certified laboratory. Booz Allen Hamilton will provide services such as high-throughput genotyping, sequencing, and gene-expression analysis, as well as developing an API for transmitting data to the ABCD and HBCD Data Centers. The contract has a five-year period of performance from September 2021 to September 2026 and does not have a set-aside designation. Task orders have been awarded to Booz Allen Hamilton totaling over $33 million to date for the first four years of the contract, with the work being performed in McLean, Virginia. This contract aims to establish a comprehensive biorepository and analysis center to support critical NIDA research initiatives on brain development and child health.
Generated 12/18/24, 9:06 AM